JW PHARMACEUTICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,550 KRW | -0.81% |
|
-0.81% | -14.06% |
| 03-14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
Evolution of the average Target Price on JW Pharmaceutical Corporation
Price target over the last 5 years
History of analyst recommendation changes
c07e61a56a9e75ddcd2594ce32775a6f.X-b6SR3SjJR0meCcxO2XidVhY-azP1vokLqbvSEKPKw.KKfMD0SluOMXxqr_nLih7I87O9PfWSuE3_HP_2lPVJVv0bx5eYbF8ybdkw~3a325678ceaa564d2bdde1b2533f30b7
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
30,550
KRW
Average target price
41,667
KRW
Spread / Average Target
+36.39%
High Price Target
45,000
KRW
Spread / Highest target
+47.30%
Low Price Target
38,000
KRW
Spread / Lowest Target
+24.39%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A001060 Stock
- Consensus JW Pharmaceutical Corporation
